San Antonio, TX, United States of America

Caroline Danielle Kusmierz

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Northwestern University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Caroline Danielle Kusmierz. Retrieved from https://idiyas.com/inventor/caroline-danielle-kusmierz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Caroline Danielle Kusmierz: Innovator in Antiviral Vaccines

Introduction

Caroline Danielle Kusmierz is a prominent inventor based in San Antonio, TX (US). She has made significant contributions to the field of antiviral vaccines, showcasing her expertise and dedication to advancing medical science.

Latest Patents

Kusmierz holds a patent for "Antiviral Vaccines Using Spherical Nucleic Acids." This innovative approach aims to enhance the effectiveness of vaccines, potentially leading to better prevention strategies against viral infections. She has 1 patent to her name, reflecting her commitment to research and development in this critical area.

Career Highlights

Caroline is affiliated with Northwestern University, where she collaborates with leading researchers and contributes to groundbreaking studies. Her work is characterized by a focus on utilizing advanced technologies to improve vaccine efficacy and safety.

Collaborations

Throughout her career, Kusmierz has worked alongside esteemed colleagues, including Chad A. Mirkin and Michelle Hope Teplensky. These collaborations have enriched her research and expanded the impact of her innovations in the scientific community.

Conclusion

Caroline Danielle Kusmierz is a trailblazer in the field of antiviral vaccines, with a notable patent and a strong academic background. Her contributions are paving the way for future advancements in vaccine technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…